Quarterly report pursuant to Section 13 or 15(d)

CONDENDSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT) (Unaudited)

v3.22.1
CONDENDSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT) (Unaudited) - USD ($)
Total
Subordinate Voting Shares
Super Voting Shares
Share Capital
Accumulated Deficit
Balance, Shares at Dec. 31, 2020   57,617,000 203,000    
Balance, Amount at Dec. 31, 2020 $ 31,156,000     $ 125,540,000 $ (94,384,000)
Net Loss (6,719,000)     0 (6,719,000)
Shares Issued In Connection With Conversion Of Convertible Debentures, Shares   1,390      
Shares Issued In Connection With Conversion Of Convertible Debentures, Amount 277     277 0
Issuance Of Shares Associated With Acquisitions, Shares   22,644      
Issuance Of Shares Associated With Acquisitions, Amount 34,237     34,237 0
Exercise Of Warrants, Shares   1,324      
Exercise Of Warrants, Amount 665     665 0
Share-based Compensation Expense, Shares   246      
Share-based Compensation Expense, Amount 287     287 0
Balance, Shares at Mar. 31, 2021   83,221,000 203,000    
Balance, Amount at Mar. 31, 2021 59,903,000     161,006,000 (101,103,000)
Balance, Shares at Dec. 31, 2021   111,806,000 203,000    
Balance, Amount at Dec. 31, 2021 70,307,000     189,368,000 (119,061,000)
Net Loss (4,057,000)     0 (4,057,000)
Share-based Compensation Expense, Shares   220      
Share-based Compensation Expense, Amount 161     161 0
Balance, Shares at Mar. 31, 2022   112,026,000 203,000    
Balance, Amount at Mar. 31, 2022 $ 66,411,000     $ 189,529,000 $ (123,118,000)